British journal of Cancer |
The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence |
nov. 15 |
1 ♥ |
Cancers autres |
British journal of Cancer |
Tumour-stroma ratio and prognosis in gastric adenocarcinoma |
aoû. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours |
mar. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer |
aoû. 18 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Long-term outcomes of patients with 10 or more colorectal liver metastases |
aoû. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies |
mar. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study |
aoû. 16 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study |
avr. 19 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study |
aoû. 16 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study |
avr. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer |
Jan. 17 |
2 ♥ |
Cancer colorectal |
British journal of Cancer |
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study. |
fév. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228) |
sep. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial |
avr. 19 |
1 ♥ |
Carcinome hépatocellulaire (CHC) |
British journal of Cancer |
The impact of age on complications, survival, and cause of death following colon cancer surgery |
Jan. 17 |
3 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. |
déc. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study |
juil. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Incidence of Diabetes in Colorectal Cancer Survivors |
juin. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial |
Jan. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States |
déc. 18 |
1 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of the National Cancer Institute (JNCI) |
Risk of Advanced Neoplasia Using the National Cancer Institute’s Colorectal Cancer Risk Assessment Tool |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |